You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Prod ucts (% of Sales by Lead ing 5): 20-25%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 40-45%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
85-90%<br />
Prin ci pal Prod ucts:<br />
SANDOZ-DILTIAZEM T (cal cium an tag o nist plain)<br />
SANDOZ-BUPROPRION (an ti de pres sant)<br />
SANDOZ-FELODIPINE (cal cium an tag o nist plain)<br />
SANDOZ-BISOPROLOL (beta-blocker agent plain)<br />
SUPEUDOL (an al ge sic nar cotic)<br />
Ther a peu tic Range:<br />
cal cium an tag o nists 12%<br />
an al ge sics 10%<br />
antibacterials sys temic 10%<br />
psychoanaleptics 7%<br />
an es thet ics 6%<br />
Lead ing Dose Forms:<br />
vi als 33%<br />
coated tab lets 21%<br />
tab lets 16%<br />
cap sules 11%<br />
am poules 8%<br />
CHILE<br />
NOVARTIS<br />
Full Name: Novartis Chile SA<br />
Postal Ad dress: Casilla Correo 9993, San ti ago<br />
de Chile<br />
Street Ad dress: Rosario Norte 615, Piso 9,<br />
Edificio Mis tral - Las Condes, San ti ago de Chile<br />
Tel: +56 2 3500200<br />
Fax: +56 2 2244283<br />
Email: novartis.chile@pharma.novartis.com<br />
Home Page: www.novartis.cl<br />
De scrip tion: Im porter, dis trib u tor, pro moter,<br />
sales/detailer. Prod uct ranges in clude: phar ma -<br />
ceu ti cal prod ucts (branded, pre scrip tion,<br />
non-pre scrip tion), hos pi tal pharmaceuticals, oph -<br />
thal mic prod ucts, vet er i nary pharmaceuticals. Es -<br />
tab lished 1997. Di vi sions include: Novartis Self<br />
Med.<br />
Con tacts (Pharm): Chair man: James Har old;<br />
Com mer cial Op er a tions: James Har old; Man u fac -<br />
ture: Jac que line Cas tro; Mar ket Re search: Julio<br />
Sanhueza; Re search & De vel op ment: Elisa<br />
Berdichevsky; Gen eral Con tact: Monica Zell K.<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 20-22 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 45-50%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 65-70%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
TAREG-D (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
TAREG (an gio ten sin-II an tag o nist plain)<br />
NEO-SINTROM (vi ta min K an tag o nist)<br />
CATAFLAM (antirheumatic non-steroidal)<br />
EXELON (anti-Alz hei mer prod uct)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 34%<br />
anti rheu ma tics sys temic 11%<br />
antiepileptics 9%<br />
antithrombotic agents 7%<br />
CNS drugs other 6%<br />
Lead ing Dose Forms:<br />
tab lets 41%<br />
coated tab lets 35%<br />
cap sules 9%<br />
liq uids 7%<br />
med i cal dress ings 4%<br />
CHINA<br />
CHIRON<br />
Street Ad dress: 14th Floor - IBM Tower, Pa cific<br />
Cen tury Place, Chaoyang Dis trict, Beijing,<br />
1000027<br />
Tel: +86 10 65391262<br />
Fax: +86 10 65391060<br />
Email: info@chironvaccines.com<br />
HEXAL<br />
Full Name: Tianjin Hexal Phar ma ceu ti cal Co. Ltd<br />
Street Ad dress: Fujiang Road, Xijiangjing,<br />
Xiqing Dis trict, Tianjin, 300112<br />
Tel: +86 22 27539488<br />
Fax: +86 22 27513010<br />
Sub sid iary of: Sandoz, Ger many (joint)<br />
NOVARTIS<br />
Full Name: Beijing Novartis Pharma Ltd<br />
Street Ad dress: 14/F, China World Tower 2, No.<br />
1 Jian Guo Men Wai Ave, Chaoyang Dis trict,<br />
Beijing, 100004<br />
Tel: +86 10 65058833<br />
Fax: +86 10 65057311<br />
Home Page: www.pharma-novartis.com.cn<br />
De scrip tion: Man u fac turer, packager/as sem -<br />
bler, im porter, ex porter, pro moter, sales/detailer.<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 158
Change language